期刊文献+

氢质子磁共振波谱在乳腺病变中的应用价值 被引量:1

Clinical value of ^1H-MRS in breast disease
下载PDF
导出
摘要 目的研究乳腺氢质子磁共振波谱(1H-MRS)的代谢特征,判断其在鉴别乳腺良、恶性病变中的应用价值。方法回顾性分析有明确病理结果的57例乳腺病变(恶性32例,良性25例)及12例正常腺体的1H-MRS的代谢特征。结果32例恶性病变中有15例于3.23ppm处出现Cho峰(SNR≥2),12例Cho峰为阴性,有5例采集失败,不能确定有无Cho峰。25例良性病变中,有2例在3.23ppm处出现Cho峰(SNR<2),3例采集失败,另外20例良性病变及12例正常腺体中均未探及Cho峰。以Cho峰鉴别良恶性病变的平均敏感性为55.6%±7.1%,特异性为100%,准确性75.5%±6.1%,阳性预测值为100%,阴性预测值为64.7%±6.8%。Kappa=0.529±0.104,P=0.000<0.05,有统计学意义。结论1H-MRS在鉴别乳腺良、恶性病变中有一定的实用价值,但由于影响因素较多,目前敏感性较低,其临床应用价值有待进一步研究。 Objective To study the ^1H-MRS metabolic features of breast diseases and assess the clinical usefulness in distinguishing benign from malignant lesions.Methods Analyze retrospectively the ^1H-MRS metabolic features of 57 breast diseases(32 malignant and 25 benign)confirmed by pathology and 12 normal breast.Results Spectroscopy findings were positive in 15 of 32 carcinomas(show increased choline resonance peak at 3.23 ppm,SNR≥2)but negative for all benign lesions and normal breast.Eight cases were(5 malignant and 3 benign)failed(ie,determination of positive or negative of choline could not be made).The mean sensitivity and specificity were 55.6%±7.1% and 100% respectively,mean accuracy was 75.5%±6.1%,and positive predictive value was 100%,the negative predictive value was 64.7%±6.8%.Kappa=0.529±0.104,P=0.000〈0.05.Conclusion ^1H-MRS is useful in distinguishing benign from malignant lesions,but the sensitivity of choline is low owe to many influencing factors now.The clinical value of spectroscopy want to be study further.
出处 《中国医学影像技术》 CSCD 北大核心 2007年第11期1618-1621,共4页 Chinese Journal of Medical Imaging Technology
关键词 乳腺疾病 乳腺肿瘤 磁共振波谱学 Breast disease Breast neoplasms Magnetic resonance spectroscopy
  • 相关文献

参考文献10

  • 1Castillo M.Kwock L,Mukherji SK,et al.Clinical appliations of proton MR spectroscopy[J].AJNR,1996,7(1):1-15.
  • 2Bartella L,Morris EA,Dershaw DD,et al.Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for reast cancer diagnosis:preliminary study[J].Radiology,2006,239(3):686-692.
  • 3Yeung DK,Cheung HS,Tse GM.Human breast lesions:characterization with contrast enhanced in vivo proton MR spectroscopyinitial results[J].Radiology,2001,220(1):40-46.
  • 4Mackinnon WB,Barty PA,Malycha PL,et al.Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy[J].Radiology,1997,204(3):661-666.
  • 5Tse GM,Cheang HS,Pang LM.et al.Characterization of lesions of the breast with proton MR spectroscopy:comparison of carcinomas,benign lesions,and phyllodes tumors[J].AJR,2003,181(5):1267-1272.
  • 6赵斌,蔡世峰,于台飞,彭洪娟,李慧华.MR氢质子波谱在乳腺肿块应用中的价值及技术干扰因素分析[J].中华放射学杂志,2006,40(3):281-284. 被引量:32
  • 7Jacobs MA,Barker PB,Argani P,et al.Combined dynamic contrast enhanced breast MR and proton spectroscopie imaging :a feasibility study[J].J magn Reson Imaging,2005,21(1):23-26.
  • 8Kvistad KA,Bakken Ij,Gribbestad IS,et al.Characterization of neoplastic and normal human breast tissues with in vivo 1H-MR spectroscopy[J].J Magn Reson Imaging,1999,10(2):159-164.
  • 9Cecil KM,Schnall MD,Siegelman ES,et al.The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy[J].Breast Cancer Res Treat,2001,68(2):45-54.
  • 10Jagannathan NR,Seenu V,Kumar M.Potential of in vivo proton MR spectroscopy in the assessment of breast lesions without the use of contrast agent[J].Radiology,2002,223(1):281-282.

二级参考文献11

  • 1Sinha S,Lucas-Quesada FA,DeBruhl ND,et al.Multifeature analysis of Gd-enhanced MR images of breast lesions.J Magn Reson Imaging,1997,7:1016-1026.
  • 2Kuhl CK,Mielcareck P,Klaschik S,et al.Dynamic breast MR imaging:are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology,1999,211:101-110.
  • 3Brinck U,Fischer U,Korabiowska M,et al.The variability of fibroadenoma in contrast-enhanced dynamic MR mammography.AJR,1997,168:1331-1334.
  • 4Negendank W.Studies of human tumors by MRS:a review (Review).NMR Biomed,1992,5:303-324.
  • 5Cecil KM,Schnall MD,Siegelman ES,et al.The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.Breast Cancer Res Treat,2001,68:45-54.
  • 6Katz-Brull R,Lavin PT,Lenkinski RE.Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions(Review).J Natl Cancer Inst,2002,94:1197-1203.
  • 7Kvistad KA,Bakken IJ,Gribbestad IS,et al.Characterization of neoplastic and normal human breast tissues with in vivo 1H-MR spectroscopy.J Magn Reson Imaging,1999,10:159-164.
  • 8Roebuck JR,Cecil KM,Schnall MD,et al.Human breast lesions:characterization with proton MR spectroscopy.Radiology,1998,209:269-275.
  • 9Mackinnon WB,Barry PA,Malycha PL,et al.Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.Radiology,1997,204:661-666.
  • 10Jagannathan NR,Seenu V,Kumar M.Potential of in Vivo proton MR spectroscopy in the assessment of breast lesions without the use of contrast agent.Radiology,2002,223:281-282.

共引文献31

同被引文献20

  • 1Castillo M, Kwock L, Mukherji SK, et al. Clinical applications of proton MR spectroscopy. AJNR, 1996,7 : 1.
  • 2Bartella L, Morris EA, Dershaw DD, et al, Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology, 2006,239:686.
  • 3Yeung DK, Cheung HS,Tse GM. Human breast lesions:characterization with contrast enhanced in vivo proton MR spectroscopy-initial results. Radiology, 2001,220:40.
  • 4Mackinnon WB, Barry PA, Malycha PL, et al, Fine-needle biopsyspecimens of benign breast lesions distinguished from invasive cancerex vivo with proton MR spectroscopy. Radiology, 1997,204 : 661.
  • 5Tse GM, Cheang HS, Pang LM, et al. Characterization of lesions of the breast with proton MR spectroscopy:comparison of carcino2mas,benign lesions,and phyllodes tumors. AJR ,2003,181:1267.
  • 6Zhao B ,Cai SF ,Yu TF ,et al. Study of clinical value and influen-cing faetor of ^1H-MR spectroscopy in mammary tumours. Chin J Radiol, 2006,40 : 281.
  • 7Jacobs MA, Barker PB, Arganl P, et al. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging,2005,21:23.
  • 8Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal Human breast tissues with in vivo ^1H-MR spectroscopy. J Magn Reson hnaging, 1999,10:159.
  • 9Cecil KM, Schnall MD, Siegchnan ES, et al. The evaluation of Human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat,2001,68:45.
  • 10Jagannathan NR,Seenu V, Kumar M. Potential of in vivo proton MR spectroscopy in the assessment of breast lesions without the use of contrast agent. Radiology ,2002,223:281.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部